Executive Panel: Scaling AI for Drug Design and Optimization
- Discuss how AI is reshaping the overall paradigm of molecular design and optimization in modern drug discovery.- Explore the challenges of scaling AI from promising tools to fully integrated discovery platforms across organizations.- Examine how collaboration between computational scientists, medicinal chemists and automation platforms is enabling truly scalable AI-driven chemistry.